Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntington's disease transgenic mice

Molecular and Cellular Neuroscience

Volumn 20, Issue 4, 2002, Pages 638-648

  Liévens, Jean Charles ^a   Woodman, Benjamin ^a   Mahal, Amarbirpal ^a   Bates, Gillian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN SUBUNIT; REGULATOR PROTEIN; SYNAPSIN I;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DEPHOSPHORYLATION; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUNTINGTON CHOREA; MOUSE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0036382909     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2002.1152     Document Type: Article

References (61)

1. Bahler, M., and Greengard, P. (1987). Synapsin I bundles F-actin in a phosphorylation-dependent manner. Nature 326: 704-707.
2. Baines, A. J., and Bennett, V. (1986). Synapsin I is a microtubule-bundling protein. Nature 319: 145-147.
3. Benfenati, F., Neyroz, P., Bahler, M., Masotti, L., and Greengard, P. (1990). Time-resolved fluorescence study of the neuron-specific phosphoprotein synapsin. I. Evidence for phosphorylation-dependent conformational changes. J. Biol. Chem. 265: 12584-12895.
4. Benfenati, F., Valtorta, F., Bahler, M., and Greengard, P. (1989). Synapsin I, a neuron-specific phosphoprotein interacting with small synaptic vesicles and F-actin. Cell. Biol. Int. Rep. 13: 1007-1021.
5. Benfenati, F., Valtorta, F., Chieregatti, E., and Greengard, P. (1992). Interaction of free and synaptic vesicle-bound synapsin I with F-actin. Neuron 8: 377-386.
6. Bennett, A. F., and Baines, A. J. (1992). Bundling of microtubules by synapsin. 1. Characterization of bundling and interaction of distinct sites in synapsin 1 head and tail domains with different sites in tubulin. Eur. J. Biochem. 206: 783-792.
7. Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A., and Greengard, P. (2000). Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc. Natl. Acad. Sci. USA 97: 6809-6814.
8. Biziere, K., and Coyle, J. T. (1979). Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum. J. Neurosci. Res. 4: 383-398.
9. Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., and Morton, A. J. (1999). Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19: 3248-3257.
10. Cha, J. H., Frey, A. S., Alsdorf, S. A., Kerner, J. A., Kosinski, C. M., Mangiarini, L., Penney, J. B., Jr., Davies, S. W., Bates, G. P., and Young, A. B. (1999). Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Phil. Trans. R. Soc. Lond. B Biol. Sci. 354: 981-989.
11. Cha, J. H., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., and Young, A. B. (1998). Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl. Acad. Sci. USA 95: 6480-9485.
12. Chi, P., Greengard, P., and Ryan, T. A. (2001). Synapsin dispersion and reclustering during synaptic activity. Nature Neurosci. 4: 1187-1193.
13. Czernik, A. J., Girault, J. A., Nairn, A. C., Chen, J., Snyder, G., Kebabian, J., and Greengard, P. (1991). Production of phosphorylation state-specific antibodies. Methods Enzymol. 201: 264-283.
14. Czernik, A. J., Pang, D. T., and Greengard, P. (1987). Amino acid sequences surrounding the cAMP-dependent and calcium/calmodulin-dependent phosphorylation sites in rat and bovine synapsin I. Proc. Natl. Acad. Sci. USA 84: 7518-7522.
15. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., and Bates, G. P. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537-548.
16. Deckel, A. W., Gordinier, A., Nuttal, D., Tang, V., Kuwada, C., Freitas, R., and Gary, K. A. (2001). Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: Effects of L-NAME on symptom progression. Brain Res 919: 70-81.
17. Denovan-Wright, E. M., and Robertson, H. A. (2000). Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice. Neuroscience 98: 705-713.
18. Foroud, T., Siemers, E., Kleindorfer, D., Bill, D. J., Hodes, M. E., Norton, J. A., Conneally, P. M., and Christian, J. C. (1995). Cognitive scores in carriers of Huntington's disease gene compared to non-carriers. Ann. Neurol. 37: 657-664.
19. Fuller, G., Veitch, K., Ho, L. K., Cruise, L., and Morris, B. J. (2001). Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase. Brain Res. Mol. Brain Res. 89: 126-132.
20. Galarraga, E., Surmeier, D. J., and Kitai, S. T. (1990). Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons. Brain Res. 512: 269-576.
21. Greengard, P., Valtorta, F., Czernik, A. J., and Benfenati, F. (1993). Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259: 780-785.
22. Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., and Holbrook, N. J. (1996). Activation of mitogen-activated protein kinase by H2O2: Role in cell survival following oxidant injury. J. Biol. Chem. 271: 4138-4142.
23. Hansson, O., Peters n, A., Leist, M., Nicotera, P., Castilho, R. F., and Brundin, P. (1999). Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl. Acad. Sci. USA 96: 8727-8732.
24. Harper, P. S. (1996). Huntington's Disease, Vol. 31, 2nd ed. Saunders, London.
25. HDCRG (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72: 971-983.
26. Hilfiker, S., Pieribone, V. A., Czernik, A. J., Kao, H. T., Augustine, G. J., and Greengard, P. (1999). Synapsins as regulators of neurotransmitter release. Phil. Trans. R. Soc. Lond. B Biol. Sci. 354: 269-279.
27. Iga, M., Inui, M., and Sobue, K. (1997). Characterization of the interaction between synapsin I and calspectin (brain spectrin or fodrin). Biochem. Biophys. Res. Commun. 231: 852-825.
28. Jovanovic, J. N., Benfenati, F., Siow, Y. L., Sihra, T. S., Sanghera, J. S., Pelech, S. L., Greengard, P., and Czernik, A. J. (1996). Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc. Natl. Acad. Sci. USA 93: 3679-3683.
29. Jovanovic, J. N., Sihra, T. S., Nairn, A. C., Hemmings, H. C., Jr., Greengard, P., and Czernik, A. J. (2001). Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals. J. Neurosci. 21: 7944-7953.
30. Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M. F., and Levine, M. S. (2001). Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 86: 2667-2677.
31. Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., ffrench-Constant, C., Rubinsztein, D. C., Robbins, T. W., and Sahakian, B. J. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121: 1329-1341.
32. Lievens, J. C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., and Bates, G. P. (2001). Impaired glutamate uptake in the r6 Huntington's disease transgenic mice. Neurobiol. Dis. 8: 807-821.
33. Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., and Dunnett, S. B. (1999). Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 19: 10428-10437.
34. Liu, J., Albers, M. W., Wandless, T. J., Luan, S., Alberg, D. G., Belshaw, P. J., Cohen, P., MacKintosh, C., Klee, C. B., and Schreiber, S. L. (1992). Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31: 3896-3901.
35. Luthi-Carter, R., Strand, A., Peters, N. L., Solano, S. M., Hollingsworth, Z. R., Menon, A. S., Frey, A. S., Spektor, B. S., Penney, E. B., Schilling, G., et al. (2000). Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9:1259-1271.
36. Mangiarini, L., Sathasivam, K., Mahal, A., Mott, R., Seller, M., and Bates, G. P. (1997). Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nature Genet. 15: 197-200.
37. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., and Bates, G. P. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493-506.
38. Matsubara, M., Kusubata, M., Ishiguro, K., Uchida, T., Titani, K., and Taniguchi, H. (1996). Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J. Biol. Chem. 271: 21108-21113.
39. McGeer, E. G., McGeer, P. L., and Singh, K. (1978). Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract. Brain Res. 139: 381-383.
40. Menalled, L., Zanjani, H., MacKenzie, L., Koppel, A., Carpenter, E., Zeitlin, S., and Chesselet, M. F. (2000). Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp. Neurol. 162: 328-342.
41. Moriya, M., Fujinaga, K., Yazawa, M., and Katagiri, C. (1995). Immunohistochemical localization of the calcium/calmodulin-dependent protein phosphatase, calcineurin, in the mouse testis: Its unique accumulation in spermatid nuclei. Cell Tissue Res. 281: 273-281.
42. Morton, A. J., and Edwardson, J. M. (2001). Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease. J. Neurochem. 76: 166-172.
43. Morton, A. J., and Leavens, W. (2000). Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity. Brain Res. Bull. 52: 51-59.
44. Murphy, K. P., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., and Morton, A. J. (2000). Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci. 20: 5115-5123.
45. Myers, R. H., Marans, K. S., and MacDonald, M. E. (1998). Huntington's disease. In Genetic Instabilities and Hereditary Neurological Diseases (R. D. Wells and S. T. Warren, Eds.), pp. 301-323. Academic Press, San Diego.
46. Nicniocaill, B., Haraldsson, B., Hansson, O., O'Connor, W. T., and Brundin, P. (2001). Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur. J. Neurosci. 13: 206-210.
47. Orlando, L. R., Alsdorf, S. A., Penney, J. B., Jr., and Young, A. B. (2001). The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp. Neurol. 167: 196-204.
48. Perez-Severiano, F., Rios, C., and Segovia, J. (2000). Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res. 862: 234-237.
49. Petrucci, T. C., and Morrow, J. S. (1987). Synapsin I: An actin-bundling protein under phosphorylation control. J. Cell. Biol. 105: 1355-1363.
50. Sabatini, D. M., Lai, M. M., and Snyder, S. H. (1997). Neural roles of immunophilins and their ligands. Mol. Neurobiol. 15: 223-239.
51. Schiebler, W., Jahn, R., Doucet, J. P., Rothlein, J., and Greengard, P. (1986). Characterization of synapsin I binding to small synaptic vesicles. J. Biol. Chem. 261: 8383-8390.
52. Schwarzschild, M. A., Cole, R. L., Meyers, M. A., and Hyman, S. E. (199) Contrasting calcium dependencies of SAPK and ERK activations by glutamate in cultured striatal neurons. J. Neurochem. 72: 2248-2255.
53. Sihra, T. S., Wang, J. K., Gorelick, F. S., and Greengard, P. (1989). Translocation of synapsin I in response to depolarization of isolated nerve terminals. Proc. Natl. Acad. Sci. USA 86: 8108-8112.
54. Sikorski, A. F., Terlecki, G., Zagon, I. S., and Goodman, S. R. (1991). Synapsin I-mediated interaction of brain spectrin with synaptic vesicles. J. Cell. Biol. 114: 313-318.
55. Smith, M. A., Brandt, J., and Shadmehr, R. (2000). Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 403: 544-549.
56. Stanciu, M., and DeFranco, D. B. (2002). Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 277: 4010-4017.
57. Stanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., Reynolds, I., Klann, E., Angiolieri, M. R., Johnson, J. W., and De-Franco, D. B. (2000). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275: 12200-12206.
58. Tabrizi, S. J., Workman, J., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J. M., and Schapira, A. H. (2000). Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol. 47: 80-86.
59. Torri Tarelli, F., Bossi, M., Fesce, R., Greengard, P., and Valtorta, F. (1992). Synapsin I partially dissociates from synaptic vesicles during exocytosis induced by electrical stimulation. Neuron 9: 1143-1153.
60. Valtorta, F., Greengard, P., Fesce, R., Chieregatti, E., and Benfenati, F. (1992). Effects of the neuronal phosphoprotein synapsin I on actin polymerization. I. Evidence for a phosphorylation-dependent nucleating effect. J. Biol. Chem. 267: 11281-11288.
61. Vanhoutte, P., Barnier, J. V., Guibert, B., Pages, C., Besson, M. J., Hipskind, R. A., and Caboche, J. (1999). Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol. Cell. Biol. 19: 136-146.